|
|
||||||||
Investigative Ophthalmology & Visual Science, Vol 35, 1008-1018, Copyright © 1994 by Association for Research in Vision and Ophthalmology
ARTICLES AND REPORTS |
AH Danser, FH Derkx, PJ Admiraal, J Deinum, PT de Jong and MA Schalekamp
Department of Pharmacology, Erasmus University, Rotterdam, The Netherlands.
PURPOSE. Ocular tissues contain renin and ocular fluids contain prorenin in amounts that are too high to be explained by admixture with blood or diffusion from blood. It was the purpose of the present study to obtain further evidence for the presence of a local renin- angiotensin system (RAS) in the eye. METHODS. The authors measured the concentrations of angiotensins I and II (ANG I and II) in vitreous fluid and ocular tissues of anesthetized pigs and in human aqueous, vitreous, and subretinal fluid obtained during eye surgery. RESULTS. In tissues obtained from normal porcine eyes (anterior uveal tract, neural retina, retinal pigment epithelium + choroid), ANG I and II were 5- to 100-fold higher than could be accounted for by contamination with blood. ANG I and II in ocular tissues are therefore unlikely to be derived from the circulation. In porcine vitreous fluid, ANG I and II were close to the limit of detection. In addition, during a 2-hour infusion of 125I-ANG I in the rabbit, 125I-ANG I in vitreous fluid reached a level only 1% of the level in arterial plasma. Thus, in the presence of an intact blood-retinal barrier, little or no ANG I or II enters the vitreous compartment. In human ocular fluids obtained from diseased eyes, ANG I and II levels were readily measurable and correlated linearly with the level of serum albumin, indicating that after partial breakdown of the BRB, diffusion of ANG I and II from the circulation into the eye may occur. CONCLUSION. Results indicate that both ANG I and II are generated locally in ocular tissues with little leakage into ocular fluids. These findings, together with previously published data on renin and prorenin, show a high degree of compartmentalization of the RAS in the eye and are in agreement with similar findings in other tissues, where there is evidence for the existence of a local RAS.
This article has been cited by other articles:
![]() |
H. Yang, K. Hirooka, K. Fukuda, and F. Shiraga Neuroprotective Effects of Angiotensin II Type 1 Receptor Blocker in a Rat Model of Chronic Glaucoma Invest. Ophthalmol. Vis. Sci., December 1, 2009; 50(12): 5800 - 5804. [Abstract] [Full Text] [PDF] |
||||
![]() |
V P Costa, E S Arcieri, and A Harris Blood pressure and glaucoma Br J Ophthalmol, October 1, 2009; 93(10): 1276 - 1282. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Striker, F. Praddaude, O. Alcazar, S. W. Cousins, and M. E. Marin-Castano Regulation of angiotensin II receptors and extracellular matrix turnover in human retinal pigment epithelium: role of angiotensin II Am J Physiol Cell Physiol, December 1, 2008; 295(6): C1633 - C1646. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. Gallego, M. E Craig, S. Hing, and K. C Donaghue Role of blood pressure in development of early retinopathy in adolescents with type 1 diabetes: prospective cohort study BMJ, August 26, 2008; 337(aug26_1): a918 - a918. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kurihara, Y. Ozawa, N. Nagai, K. Shinoda, K. Noda, Y. Imamura, K. Tsubota, H. Okano, Y. Oike, and S. Ishida Angiotensin II Type 1 Receptor Signaling Contributes to Synaptophysin Degradation and Neuronal Dysfunction in the Diabetic Retina Diabetes, August 1, 2008; 57(8): 2191 - 2198. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vaajanen, H. Vapaatalo, H. Kautiainen, and O. Oksala Angiotensin (1-7) Reduces Intraocular Pressure in the Normotensive Rabbit Eye Invest. Ophthalmol. Vis. Sci., June 1, 2008; 49(6): 2557 - 2562. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Chen, A. M. Guo, P. A. Edwards, G. Trick, and A. G. Scicli Role of NADPH oxidase and ANG II in diabetes-induced retinal leukostasis Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1619 - R1629. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. deS. Senanayake, J. Drazba, K. Shadrach, A. Milsted, E. Rungger-Brandle, K. Nishiyama, S.-I. Miura, S. Karnik, J. E. Sears, and J. G. Hollyfield Angiotensin II and Its Receptor Subtypes in the Human Retina Invest. Ophthalmol. Vis. Sci., July 1, 2007; 48(7): 3301 - 3311. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kurihara, Y. Ozawa, K. Shinoda, N. Nagai, M. Inoue, Y. Oike, K. Tsubota, S. Ishida, and H. Okano Neuroprotective Effects of Angiotensin II Type 1 Receptor (AT1R) Blocker, Telmisartan, via Modulating AT1R and AT2R Signaling in Retinal Inflammation Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5545 - 5552. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hashizume, Y. Mashima, T. Fumayama, Y. Ohtake, I. Kimura, K. Yoshida, K. Ishikawa, N. Yasuda, T. Fujimaki, R. Asaoka, et al. Genetic Polymorphisms in the Angiotensin II Receptor Gene and Their Association with Open-Angle Glaucoma in a Japanese Population Invest. Ophthalmol. Vis. Sci., June 1, 2005; 46(6): 1993 - 2001. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sarlos and J. L. Wilkinson-Berka The Renin-Angiotensin System and the Developing Retinal Vasculature Invest. Ophthalmol. Vis. Sci., March 1, 2005; 46(3): 1069 - 1077. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhang, M. Lassila, M. E. Cooper, and Z. Cao Retinal Expression of Vascular Endothelial Growth Factor Is Mediated by Angiotensin Type 1 and Type 2 Receptors Hypertension, February 1, 2004; 43(2): 276 - 281. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. N. Thomas, J. A.J.H. Critchley, B. Tomlinson, V. T.F. Yeung, D. Lam, C. S. Cockram, and J. C.N. Chan Renin-Angiotensin System Gene Polymorphisms and Retinopathy in Chinese Patients With Type 2 Diabetes Diabetes Care, May 1, 2003; 26(5): 1643 - 1644. [Full Text] [PDF] |
||||
![]() |
C. J. Moravski, S. L. Skinner, A. J. Stubbs, S. Sarlos, D. J. Kelly, M. E. Cooper, R. E. Gilbert, and J. L. Wilkinson-Berka The Renin-Angiotensin System Influences Ocular Endothelial Cell Proliferation in Diabetes: Transgenic and Interventional Studies Am. J. Pathol., January 1, 2003; 162(1): 151 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
W D. Strain and N. Chaturvedi Review: The renin-angiotensin-aldosterone system and the eye in diabetes Journal of Renin-Angiotensin-Aldosterone System, December 1, 2002; 3(4): 243 - 246. [Abstract] [PDF] |
||||
![]() |
A B Cullinane, P S Leung, J Ortego, M Coca-Prados, and B J Harvey Renin-angiotensin system expression and secretory function in cultured human ciliary body non-pigmented epithelium Br J Ophthalmol, June 1, 2002; 86(6): 676 - 683. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Funatsu, H Yamashita, Y Nakanishi, and S Hori Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy Br J Ophthalmol, March 1, 2002; 86(3): 311 - 315. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Nadal, G. M. Scicli, L. A. Carbini, and A. G. Scicli Angiotensin II stimulates migration of retinal microvascular pericytes: involvement of TGF-beta and PDGF-BB Am J Physiol Heart Circ Physiol, February 1, 2002; 282(2): H739 - H748. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Filippatos, N. Gangopadhyay, O. Lalude, N. Parameswaran, S. I. Said, W. Spielman, and B. D. Uhal Regulation of apoptosis by vasoactive peptides Am J Physiol Lung Cell Mol Physiol, October 1, 2001; 281(4): L749 - L761. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Otani, H. Takagi, H. Oh, S. Koyama, and Y. Honda Angiotensin II Induces Expression of the Tie2 Receptor Ligand, Angiopoietin-2, in Bovine Retinal Endothelial Cells Diabetes, April 1, 2001; 50(4): 867 - 875. [Abstract] [Full Text] |
||||
![]() |
C. J. Moravski, D. J. Kelly, M. E. Cooper, R. E. Gilbert, J. F. Bertram, S. Shahinfar, S. L. Skinner, and J. L. Wilkinson-Berka Retinal Neovascularization Is Prevented by Blockade of the Renin-Angiotensin System Hypertension, December 1, 2000; 36(6): 1099 - 1104. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Otani, H. Takagi, H. Oh, K. Suzuma, M. Matsumura, E. Ikeda, and Y. Honda Angiotensin II-Stimulated Vascular Endothelial Growth Factor Expression in Bovine Retinal Pericytes Invest. Ophthalmol. Vis. Sci., April 1, 2000; 41(5): 1192 - 1199. [Abstract] [Full Text] |
||||
![]() |
A. Otani, H. Takagi, K. Suzuma, and Y. Honda Angiotensin II Potentiates Vascular Endothelial Growth Factor–Induced Angiogenic Activity in Retinal Microcapillary Endothelial Cells Circ. Res., March 23, 1998; 82(5): 619 - 628. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Matsugi, Q. Chen, and D. R. Anderson Contractile Responses of Cultured Bovine Retinal Pericytes to Angiotensin II Arch Ophthalmol, October 1, 1997; 115(10): 1281 - 1285. [Abstract] [PDF] |
||||
![]() |
S. M. Brown and L. M. Jampol New Concepts of Regulation of Retinal Vessel Tone Arch Ophthalmol, February 1, 1996; 114(2): 199 - 204. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |